Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors

…, J Conley, B Tillotson, P O'Hearn, S Smith…

文献索引：Liu, Tao; Nair, Somarajan J.; Lescarbeau, Andre; Belani, Jitendra; Peluso, Stephane; Conley, James; Tillotson, Bonnie; OHearn, Patrick; Smith, Sherri; Slocum, Kelly; West, Kip; Helble, Joseph; Douglas, Mark; Bahadoor, Adilah; Ali, Janid; McGovern, Karen; Fritz, Christian; Palombella, Vito J.; Wylie, Andrew; Castro, Alfredo C.; Tremblay, Martin R. Journal of Medicinal Chemistry, 2012 , vol. 55, # 20 p. 8859 - 8878,20 Title/Abstract Full Text Show Details Liu, Tao; Nair, Somarajan J.; Lescarbeau, Andre; Belani, Jitendra; Peluso, Stephane; Conley, James; Tillotson, Bonnie; OHearn, Patrick; Smith, Sherri; Slocum, Kelly; West, Kip; Helble, Joseph; Douglas, Mark; Bahadoor, Adilah; Ali, Janid; McGovern, Karen; Fritz, Christian; Palombella, Vito J.; Wylie, Andrew; Castro, Alfredo C.; Tremblay, Martin R. Journal of Medicinal Chemistry, 2012 , vol. 55, # 20 p. 8859 - 8878

全文：HTML全文

被引用次数: 28

摘要

Misregulation of protein translation plays a critical role in human cancer pathogenesis at many levels. Silvestrol, a cyclopenta [b] benzofuran natural product, blocks translation at the initiation step by interfering with assembly of the eIF4F translation complex. Silvestrol has a complex chemical structure whose functional group requirements have not been systematically investigated. Moreover, silvestrol has limited development potential due to ...